Protagonist Therapeutics Inc (PTGX)

Exchange
NASDAQ
Symbol
PTGX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.
Country
USA

Stock price

At close: September 3, 2025

  • Open
    58.25
  • High
    59.51
  • Low
    57.49
  • Close
    58.11
  • Volume
    987,685

Financial ratios

Dec 31, 2024